Much still needs to be done to get treatment to those who need it and to meet the UNAIDS-endorsed goal to achieve universal access by 2015, according to a new survey examining 25 HIV indicators assessing strategies, tools and policies to get the best HIV treatment to more people, sooner. Medecins Sans Frontieres (MSF) released […]
First potential participants screened Tuesday for inclusion in ASPIRE trial
Scientists presented progress in assessing the potential of a vaginal ring containing the potent antiretroviral drug dapivirine in preventing HIV infection in women, as two studies to assess its safety and efficacy move into Phase III.
The following is a guest post from Suzanne Ehlers, President and CEO of Population Action International (PAI) and Charles Lyons, President and CEO of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF). With the conclusion of the international London Summit on Family Planning earlier this month, the global health community has shifted its focus to the […]
To understand what Chief Mumena is doing, you have to understand first how strong the bonds of tradition have been to tribal culture. It passed from generation to generation without pen and paper, with ceremonies and stories holding it together. “People are custodians of their culture; that is why it has survived,” Chief Mumena says. […]
Angelo Kaggwa, a 29-year-old Ugandan and a program coordinator with AVAC, shared his personal experience with male circumcision with a packed audience comprised largely of Africans at an International AIDS Conference satellite symposium Monday night entitled, Call to Action for Voluntary Medical Male Circumcision for HIV Prevention. “It took me eight years to do it […]
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]